A Meta-Analysis of Oxidative Stress Markers in Depression

Abstract

ObjectStudies have suggested that depression was accompanied by oxidative stress dysregulation, including abnormal total antioxidant capacity (TAC), antioxidants, free radicals, oxidative damage and autoimmune response products. This meta-analysis aims to analyse the clinical data quantitatively by comparing the oxidative stress markers between depressed patients and healthy controls.MethodsA search was conducted to collect the studies that measured the oxidative stress markers in depressed patients. Studies were searched in Embase, Medline, PsychINFO, Science direct, CBMDisc, CNKI and VIP from 1990 to May 2015. Data were subjected to meta-analysis by using a random effects model for examining the effect sizes of the results. Bias assessments, heterogeneity assessments and sensitivity analyses were also conducted.Results115 articles met the inclusion criteria. Lower TAC was noted in acute episodes (AEs) of depressed patients (p<0.05). Antioxidants, including serum paraoxonase, uric acid, albumin, high-density lipoprotein cholesterol and zinc levels were lower than controls (p<0.05); the serum uric acid, albumin and vitamin C levels were increased after antidepressant therapy (p<0.05). Oxidative damage products, including red blood cell (RBC) malondialdehyde (MDA), serum MDA and 8-F2-isoprostanes levels were higher than controls (p<0.05). After antidepressant medication, RBC and serum MDA levels were decreased (p<0.05). Moreover, serum peroxide in free radicals levels were higher than controls (p<0.05). There were no differences between the depressed patients and controls for other oxidative stress markers.ConclusionThis meta-analysis supports the facts that the serum TAC, paraoxonase and antioxidant levels are lower, and the serum free radical and oxidative damage product levels are higher than controls in depressed patients. Meanwhile, the antioxidant levels are increased and the oxidative damage product levels are decreased after antidepressant medication. The pathophysiological relationships between oxidative stress and depression, and the potential benefits of antioxidant supplementation deserve further research.

Does general intelligence moderate the association between inflammation and psychological distress?

“…Thirdly, it may cause oxidative stress dysfunction in the brain including abnormal total antioxidant capacity, antioxidants, free radicals, oxidative damage and autoimmune response products (Liu et al, 2015 for a review). These effects may contribute to impaired mood, cognition and perception, all of which are associated with depression .…”

Acid Folic Supplementation in Major Depressive Disorder Treatment: A Double-Blind Randomized Clinical Trial

“…Folic acid supplementation in patients with MDD may enhance their response to treatment through the reduction of homocysteine serum levels. There is also evidence to indicate that oxidative stress and reduced antioxidant function play a role in depression (45). Previous studies have well demonstrated that folic acid increases the total antioxidant capacity in the body.…”

Establishing reference values and evaluation of an in-house ferric reducing antioxidant power (FRAP) colorimetric assay in microplates

“…Excess production of ROS can lead to a situation of oxidative stress, which is responsible for many pathological processes and has an impact on the body's aging process. Oxidative damage has been implicated in the cause of many diseases, including cardiovascular disease, diabetes, neuronal degeneration, depression, cancer and probably aging [1][2][3].…”

“…To protect cells against oxidative stress, certain low molecular weight antioxidant molecules, either water-soluble (e.g., ascorbic acid) or lipid-soluble (e.g., vitamin E), are present in extracellular fluids [2,3]. The concentrations of antioxidants can be measured separately but this is not practical since their antioxidant effects are additive.…”